🇺🇸 FDA
Pipeline program

Angiotensin (1-7)

AngT-001

Phase 2 small_molecule active

Quick answer

Angiotensin (1-7) for Traumatic Brain Injury is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Traumatic Brain Injury
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials